whats the highest dose of semaglutide you can take Wegovy - When To Increase Your A new study suggests GLP-1s

PubMed 10833828

1,5 About the Trial Trial Name: A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease (FLOW) ClinicalTrials.gov ID: NCT03819153 Sponsor: Novo Nordisk A/S Completion Date: January 9, 2024 In the trial, which enrolled a total of 3533 patients with T2D or CKD, once weekly semaglutide 1 mg led to a 24% reduction in the risk of kidney disease progression and kidney and cardiovascular mortality compared with placebo (331 vs 410 events

Food and Drug Administration (FDA) indications to match

Weight loss drugs such as Mounjaro offer huge potential to tackle soaring obesity globally but are currently only available to one in 10 of those who need them, the World Health Organization has said